Ticker
TLSICompany Name
TRISALUS LIFE SCIENCES INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | Enterprise Value | Enterprise Value over EBIT |
---|---|---|---|
6/30/2025 | $ -26.33M | $ 189.19M | 0 |
3/31/2025 | $ -22.91M | $ 213.47M | 0 |
12/31/2024 | $ -26.95M | $ 193.25M | 0 |
9/30/2024 | $ -53.43M | $ 134.44M | 0 |
6/30/2024 | $ -53.45M | $ 177.84M | 0 |
3/31/2024 | $ -63.96M | $ 252.64M | 0 |
12/31/2023 | $ -59.01M | $ 250.18M | 0 |
9/30/2023 | $ -76.79M | $ 85.58M | 0 |
6/30/2023 | $ -74.65M | $ 123.68M | 0 |
3/31/2023 | $ 2.85M | $ 88.19M | 30.92 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV / EBIT
(=) EV/EBIT
EV/EBIT for TRISALUS LIFE SCIENCES INC is calculated as follows: EV [ $ 300.54M ] / EBIT [ $ -105.19K ]
(=) EV/EBIT [ 0 ]
Minimum
Dec 31, 2022
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 2.25K |
---|---|
min | 0.05 |
max | 62.03 |
average | 19.91 |
median | 16.78 |
std | 12.32 |